NDA 021952 · Bayer Healthcare LLC
Claritin
Loratadine · Oral
Last checked: Nov 20, 2026Latest source record: May 9, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2008
Jun 16, 2008
Approved uses
1
Original approval plus efficacy supplements
Registered trials
89
27 Phase 3, 6 recruiting
FAERS reports
103,057
49,212 serious, 4,538 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 16, 2008 Original approval · Type 3 - New Dosage Form ReviewLetterSummary Review
1 products under this application
- CLARITIN · LORATADINE 10MG · CAPSULE, ORAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Loratadine" as an intervention, any sponsor and status, largest first.
- Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)Pivotal-lookingCompleted
Organon and CoIndustry
NCT00979901 · 1,577 participants · Start Mar 2000 · Primary completion May 2000
Drug: Comparator: montelukast; Comparator: loratadine and 2 more · For: Seasonal Allergic Rhinitis
- Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)Pivotal-lookingCompleted
ALK-Abelló A/SIndustry
NCT01700192 · 1,482 participants · Start Jan 2013 · Primary completion Apr 2015
Drug: MK-8237 tablets; Placebo tablets and 4 more · For: Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Nonseasonal
- Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)Pivotal-lookingCompleted
Organon and CoIndustry
NCT00972738 · 1,214 participants · Start Apr 2001 · Primary completion Jul 2001
Drug: montelukast sodium; Comparator: loratadine and 1 more · For: Seasonal Allergic Rhinitis
- Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)Pivotal-lookingCompleted
Organon and CoIndustry
NCT00319995 · 1,095 participants · Start Mar 1, 2006 · Primary completion Jun 1, 2006
Drug: loratadine; montelukast · For: Rhinitis, Allergic, Seasonal
- Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)Pivotal-lookingCompleted
Organon and CoIndustry
NCT00963469 · 1,079 participants · Start Aug 2001 · Primary completion Nov 2001
Drug: montelukast sodium; Comparator: loratadine and 1 more · For: Seasonal Allergic Rhinitis
- Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)Pivotal-lookingCompleted
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT02478398 · 1,025 participants · Start Jul 20, 2015 · Primary completion Nov 9, 2018
Drug: Short ragweed pollen allergen extract; Placebo and 5 more · For: Rhinitis, Allergic, Seasonal
- Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)Pivotal-lookingCompleted
Organon and CoIndustry
NCT00963599 · 907 participants · Start Sep 1999 · Primary completion Nov 1999
Drug: Comparator: montelukast/loratadine; Comparator: montelukast and 2 more · For: Seasonal Allergic Rhinitis
- A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)Pivotal-lookingCompleted
Organon and CoIndustry
NCT00960141 · 829 participants · Start Aug 2000 · Primary completion Oct 2000
Drug: montelukast sodium; Comparator: loratadine and 1 more · For: Seasonal Allergic Rhinitis
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective11,854
- fatigue6,591
- nausea5,790
- headache5,304
- dyspnoea4,791
- diarrhoea4,780
- off label use4,567
- dizziness4,289
- pain4,055
- rash3,368
- pruritus3,350
- cough3,083
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 965 |
| 2005 | 1,071 |
| 2006 | 1,067 |
| 2007 | 939 |
| 2008 | 1,073 |
| 2009 | 1,316 |
| 2010 | 1,637 |
| 2011 | 2,020 |
| 2012 | 3,015 |
| 2013 | 3,959 |
| 2014 | 4,683 |
| 2015 | 7,017 |
| 2016 | 8,555 |
| 2017 | 8,774 |
| 2018 | 7,746 |
| 2019 | 7,819 |
| 2020 | 7,024 |
| 2021 | 6,285 |
| 2022 | 6,083 |
| 2023 | 5,477 |
| 2024 | 5,990 |
| 2025 | 5,930 |
| 2026 | 4,611 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Efficacy of different oral H1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials.
Hong D, Weng J, Ye M, et al. · Braz J Otorhinolaryngol 2023 · Systematic Review, Network Meta-Analysis
- Acupuncture for allergic rhinitis: a systematic review and meta-analysis.
He M, Qin W, Qin Z, et al. · Eur J Med Res 2022 · Meta-Analysis, Systematic Review
- Loratadine augments emotional blushing.
Drummond PD, Lester B · Eur Neuropsychopharmacol 2018 · Controlled Clinical Trial
- Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial.
Yamprasert R, Chanvimalueng W, Mukkasombut N, et al. · BMC Complement Med Ther 2020 · Clinical Trial, Phase II, Comparative Study
- Antihistamines for atopic dermatitis (eczema): systematic review and network meta-analysis of randomised trials.
Chu AWL, Wen A, Guyatt GH, et al. · BMJ 2026 · Systematic Review, Network Meta-Analysis
- Probiotics combined with prebiotics alleviated seasonal allergic rhinitis by altering the composition and metabolic function of intestinal microbiota: a prospective, randomized, double-blind, placebo-controlled clinical trial.
Hou Y, Wang D, Zhou S, et al. · Front Immunol 2024 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Sponsor: Bayer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.